Effect of Modified Erchentang on Hif-1α and Sirtuins 1 in Patients with COPD
Wen-ying XIE,Shu JI,Li-zhi SHANG,Hong-li XUE,Zhi-yong LIU,Jing ZHANG,Xian-min ZHAO,Xiao-hui LIU,Chun-yang SUN,Chang-qing LU,Miao ZHANG,Juan-juan LIANG,Yi WANG
DOI: https://doi.org/10.13422/j.cnki.syfjx.2017100155
2017-01-01
Abstract:Objective:To observe the effect of modified Erchentang on lung function,oxidative stress,Hif-lα and Sirtuinsl (Sirtl) in patients with chronic obstructive pulmonary disease (COPD),in order to evaluate the effect and mechanism of modified Erchentang on oxidative damage and anti-inflammation in patients of COPD.Method:A multicenter,randomized single blind and placebo-controlled study was carried out.Totally 120 cases of COPD patients in acute exacerbation stage and 120 cases patients in stable stage were selected.Patients were randomly divided into modified Erchentang group and placebo-controlled group.In addition to the western medicine,modified Erchentang was additionally used in modified Erchentang group,and placebo was additionally used in control group for 14 days.The lung function was detected,and pH,PaO2,PCO2 and SaO2were measured.Ultraviolet spectrophotometer was used to detect glutathione (GSH),superoxide dismutase (SOD) and malondialdehyde (MDA).Euzyme-linked immunosorbent assay (ELISA) was used to determine the levels of interleukin (IL)-6,IL-1β,tumor necrosis factor-alpha (TNF-α) and C-reactive protein (CRP) in patients plasma of all groups before and after treatment.Real-time PCR was used to determine the expressions of Hif-1α and Sirt-1 mRNA,and content of Hif-1α and Sirt-1 in PBMCs was measured by ELISA method.The activity of Sirt1 was determinate by Enzyme-linked immune fluorescence.Result:Compared with the control group,forced expiratory volume in one second (FEV1),forced expiratory volume in one second to forced vital capacity ratio (FEV1％),PaO2,SaO2,SOD,GSH-Px,the activity of Sirtl in treatment group were higher significantly.However,the levels of PCO2,MDA,IL-1β,IL-6,TNF-α and CRP in plasma,the total number of neutrophils,inflammatory cells,the expressions of Hif-1α mRNA and the content of Hif-1α were significantly lower in COPD treatment group with modified Erchentang in acute exacerbation and stable stages than those in control group.Conclusion:Modified Erchentang has anti-oxidative damage and anti-inflammatory effect on COPD.It may weaken the oxidation damage,reduce levels of inflammation medium IL-1β,IL-6,TNF-α and CRP,prevent inflammatory progress,adjust the expressions of Hif-1α and Sirt-1 mRNA,so as to treat COPD and improve the structure and function of the lung through multiple targets and in multiple ways.